Olema Pharmaceuticals Inc...

NASDAQ: OLMA · Real-Time Price · USD
5.52
0.26 (4.94%)
At close: Aug 15, 2025, 3:59 PM
5.54
0.36%
After-hours: Aug 15, 2025, 06:03 PM EDT

Olema Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-142.29M -128.89M -129.47M -122.68M -109.63M -99.34M -96.66M -96.06M -97.28M -110.04M -104.79M -100.25M -95.24M -78.79M -71.1M -59.59M -49.72M -35.77M
Depreciation & Amortization
471K 433K 393K 365K 360K 365K 377K 386K 387K 373K 357K 333K 292K 238K 163K 94K 46K 17K
Stock-Based Compensation
21.02M 22.05M 22.58M 20.61M 19.09M 17.54M 17.26M 17.77M 17.94M 18.49M 18.83M 18.59M 18.48M 17.67M 15.91M 13.66M 10.08M 6.32M
Other Working Capital
4.85M -4.91M 6.65M 12.31M 1.95M -6.73M -6.62M -10.54M -5.05M 2.86M 2.67M -1.51M -313K 1.72M 3.51M 6.34M 3.55M 378K
Other Non-Cash Items
-5.08M 225K -28K 3.39M -1.56M 668K 2.19M -141K -324K -325K 546K 51.53M 51.47M 51.22M 50.96M 21.7M 20.69M 21.43M
Deferred Income Tax
n/a n/a n/a -4.04M -5.21M -6.31M -6.31M -2.27M -1.09M n/a n/a -49.46M -49.46M -49.46M -49.46M -21.48M -21.48M -21.48M
Change in Working Capital
-1.28M -18.65M 2.18M 5.8M 4.68M 248K -589K -4.64M 166K 6.98M 3.02M -1.68M -577K 1.6M 2.83M 4.52M 2.92M 556K
Operating Cash Flow
-127.16M -124.83M -104.35M -96.54M -92.27M -86.83M -83.73M -84.96M -80.21M -84.55M -82.06M -80.96M -75.06M -57.51M -50.69M -41.1M -36.54M -28.81M
Capital Expenditures
159K 153K n/a n/a -159K -153K n/a -173K -312K -333K -363K -889K -846K -1.19M -1.57M -927K -821K -467K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -16.51K -36.81K -36.81K -6.81K 708.7K 729K 729K 1.16M 459K 459K 459K
Purchase of Investments
-412.42M -461.72M -394.96M -290.64M -339.12M -307.34M -255.63M -215.2M -137.7M -114.88M -213.66M -189.12M -302.81M -329.96M -486.97M -467.01M -334.87M -280.16M
Sales Maturities Of Investments
333.07M 343.26M 301.59M 280.79M 257.89M 245.1M 250.76M 257.76M 226.01M 218.51M 305.5M 271.15M 351.85M 360.85M 213.1M 186.45M 67M 1M
Other Investing Acitivies
-159K -159K -312K -342.92K -169.91K -155.8K 34.59K 82.01K 88.31K 29.51M 29.44M 28.72M 16.02M -2.13M -2.56M -1.86M 10.83M -459K
Investing Cash Flow
-79.35M -118.47M -93.53M -10.02M -81.37M -62.38M -4.85M 42.4M 88M 103.3M 91.48M 81.14M 48.2M 29.71M -275.44M -281.49M -268.69M -279.63M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 88K 88K
Common Stock Repurchased
748K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.72M 1.52M 2.44M 2.16M 3.03M 4.36M 3.65M 3.4M 2.64M 663K 476K 1.02M 972K 1.42M 1.39M 220.36M 220.06M 219.54M
Financial Cash Flow
242.1M 260.22M 268.82M 25.04M 155.58M 142.02M 133.41M 133.16M 2.64M 663K 476K 1.02M 972K 1.42M 1.39M 220.36M 305.18M 328.42M
Net Cash Flow
35.58M 16.92M 70.94M -81.52M -18.07M -7.2M 44.84M 90.6M 10.43M 19.41M 9.89M 1.21M -25.9M -26.37M -324.74M -102.23M -54K 19.97M
Free Cash Flow
-127M -124.68M -104.35M -96.54M -92.43M -86.98M -83.73M -85.14M -80.52M -84.89M -82.43M -81.85M -75.91M -58.69M -52.27M -42.03M -37.36M -29.28M